Flavonoid intake and risk of Parkinson’s Disease
Objective: To prospectively examine the association between the intake of flavonoids and their subclasses (flavanones, anthocyanins, flavan-3-ols, flavonols, flavones, and polymers) and the risk of…The feasibility and efficacy of speech therapy via video call in patients with Parkinson’s disease: a preliminary study
Objective: To evaluate the feasibility and efficacy of video call-based speech therapy for patients with Parkinson’s disease (PD) with speech problems. Background: PD patients commonly…A comparative study of non-motor symptoms in Huntington’s disease and Parkinson’s disease
Objective: To assess and compare the non-motor symptoms (NMS) profile in Parkinson's disease (PD) and Huntington's disease (HD) patients using Parkinson's Disease Non-Motor Symptom Rating…Stiff-person syndrome associated with anti-Yo1 antibodies: a case report
Objective: To present an unusual presentation of paraneoplastic stiff-person syndrome (SPS). Background: SPS may have paraneoplastic, autoimmune, or cryptogenic etiology and most often be associated…Cardiovascular complications in Parkinsonism: insights from Luxembourg Parkinson’s Study
Objective: Our study aimed at determining the frequency and risk of cardiovascular diseases (CVDs) in Parkinsonian patients in the Luxembourg Parkinson’s Study (LuxPARK). Background: The…Long duration response to levodopa in advanced Parkinson disease
Objective: In patients with advanced Parkinson disease, it is possible to obtain a response to duodopa, if the dose is adjusted appropriately, even taking periods…A phase 2 randomized, double-blind, placebo-controlled trial of Ambroxol as a disease-modifying treatment for Parkinson’s disease dementia.
Objective: To evaluate the safety and tolerability of repurposing Ambroxol as a disease modifying treatment for Parkinson’s Disease Dementia (PDD). Background: Carrying a mutation in…Does fatigue in Parkinson’s disease impact one’s physical function in daily live?
Objective: To investigate fatigue at baseline and 3.5 years later and its association with balance and gait over time. Background: In Parkinson’s disease (PD), fatigue…Substantia Nigra blood-brain barrier opening in Parkinson´s disease: PET (18F-Choline) evidence of parenchymal penetration
Objective: To evaluate clinical safety, feasibility, and tissue penetration (by 18F-Choline PET) of MR-guided focused ultrasound (MRgFUS) blood-brain barrier opening (BBB-O) of the substantia nigra…Tourette Syndrome with Functional Overlay: A Diagnosis Challenge and The Role of Electrophysiological Study
Objective: To highlight the role of electrophysiological study (Ephy) as a useful diagnostic tool. Background: Tics with functional overlay are characterised by acute worsening of…
- « Previous Page
- 1
- …
- 82
- 83
- 84
- 85
- 86
- …
- 186
- Next Page »